New hope for tough thyroid cancers: drug safety study shows promise
Disease control
Completed
This study tested the safety and effectiveness of the drug lenvatinib in 50 patients with advanced thyroid cancer that had stopped responding to standard radioactive iodine treatment. Researchers monitored side effects and whether the drug helped control the cancer's growth. The …
Phase: PHASE4 • Sponsor: Eisai Pharmaceuticals India Pvt. Ltd • Aim: Disease control
Last updated Mar 12, 2026 13:50 UTC